Genomic Testing in Breast Cancer

18 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Medical oncologist William Audeh, M.D., M.S., explains how genomic testing differs from genetic testing and how results can guide decisions about chemotherapy, treatment timing and whether to extend endocrine therapy for HR-positive, HER2-negative early-stage breast cancer.
#tumorprofiling #genomictesting

00:30 Genomic vs. genetic testing: key differences
01:30 Why test early: planning surgery and treatment
03:00 Who benefits and which tests are commonly used
04:30 How results can affect treatments and outcomes
05:45 Advocate for yourself and questions to ask your care team
Categoria
Oncology
Commenta per primo questo video.

Prossimo